Teva Pharmaceutical Stock Price (NYSE:TEVA)

Add to My Stocks
$25.17 $0.48 (1.87%) TEVA stock closing price Aug 21, 2018 (Closing)
Prev Close* : $25.65
Market Cap:
$26.08B
Day Low: $25.01
52 Week Low: $10.85
Open: $25.73
Volume: -
Day High: $25.96
52 Week High: $25.96
Dividend:
0.14

Latest Stock Market News

Latest Articles

Teva Pharmaceutical News - From Partners

TEVA Stockcharts

View TEVA PE ratio, PS ratio stocks charts and compare with peers.
TEVA Chart
Note: Compare Teva Pharmaceutical stock price history with the index and industry peers.

Teva Pharmaceutical Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
1.18
PB ratio (
price to book ratio
)
1.04

Teva Pharmaceutical Returns

ROE
(return on equity)
-59%

Teva Pharmaceutical Financial Ratios

Asset Turnover
0.29
Receivables Turnover
3.08
Debt to Equity
1.53
Dividend Yield
0.58%

TEVA Industry Peers

Company Price Change (%)
Allergan (AGN)191.110.36 (0.19%)
Mylan (MYL)38.750.34 (0.89%)
Fortress Biotech (FBIO)2.080.17 (8.9%)
Astrazeneca (AZN)38.760.09 (0.23%)
Eagle Pharma (EGRX)80.421.29 (1.63%)
Merck (MRK)69.171 (1.43%)
Glaxosmithkline (GSK)41.50.17 (0.41%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Corium (CORI)9.170.28 (3.15%)
Progenics Pharma (PGNX)7.910.24 (3.13%)
Adamas Pharma (ADMS)22.410.57 (2.61%)
Teligent (TLGT)4.350.09 (2.11%)
Mylan (MYL)38.750.34 (0.89%)
Dr. Reddy's Laboratories (RDY)34.50.28 (0.82%)
BAUSCH HEALTH (BHC)22.370.05 (0.22%)
Top gainers from Medical-Generic Drugs industry
* As of Aug 21, 2018
CompanyPriceChange (%)
Akorn (AKRX)17.921.56 (8.01%)
Teva Pharmaceutical (TEVA)25.170.48 (1.87%)
Mallinckrodt (MNK)35.970.1 (0.28%)
Supernus Pharma (SUPN)44.350.05 (0.11%)
Top losers from Medical-Generic Drugs industry
* As of Aug 21, 2018

Teva Pharmaceutical Industries Ltd (ADR) Stock News - Partner Headlines

Teva Pharmaceutical Financial Statements

income statement20172016201520142013
Net Sales or Revenues22.39B21.9B19.65B20.27B20.31B
Net Income-16.27B329M1.59B3.06B1.27B
Total Operating Expense28.31B9.01B6.87B6.46B8.27B
View Teva Pharmaceutical income statement
balance sheet20172016201520142013
Total Assets70.62B92.89B54.26B46.42B47.51B
Total Liabilities51.87B57.9B24.33B23.07B24.87B
Shareholders Equity18.75B34.99B29.93B23.36B22.64B
View Teva Pharmaceutical balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-363M1.22B967M290M968M
Net Cash from (used by) Operating Activities3.51B5.23B5.54B5.13B3.24B
Increase (Decrease) in Prop Plant And Equipment2.6B1.1B-248M-733M-844M
View Teva Pharmaceutical cash flow statement

Teva Pharmaceutical Stock Message Board

Teva Pharmaceutical stock price ended the last trading day at $25.17. Stock price or share price can be used to find the total market value of a company. Teva Pharmaceutical market cap stands at $26.08B as of Aug 21, 2018. Teva Pharmaceutical valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy TEVA stock than sell it, then Teva Pharmaceutical stock price goes up. Conversely, if more investors wanted to sell TEVA stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Teva Pharmaceutical stock quote data shows the number of shares traded. For Ex: 12,782,073 Teva Pharmaceutical shares were traded as of last trading day, as seen from Teva Pharmaceutical stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Teva Pharmaceutical does pay dividends. Teva Pharmaceutical stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.